FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2011/10/002081 [Registered on: 20/10/2011] Trial Registered Retrospectively
Last Modified On: 14/10/2011
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A Clinical Trial to study the effect of an Ayurvedic drug, Thriphalaguduchyadi vati, in children with Obesity 
Scientific Title of Study   A CLINICAL STUDY ON THE EFFICACY OF TRIPHALA GUDUCHYADI VATI IN THE MANAGEMENT OF STHAULYA (OBESITY) IN CHILDREN. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Biju KR 
Designation  Ph.D.Scholar 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  Department of Kaumarabhritya Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurveda University Jamnagar
Gujarat Ayurveda University Jamnagar Gujarat
Jamnagar
GUJARAT
361008
India 
Phone  9429807839  
Fax    
Email  drbijukr@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Kalpana S Patel 
Designation  Reader 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  Head Of the Department Department of Kaumarabhritya Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurveda University Jamnagar
Gujarat Ayurveda University Jamnagar Gujarat
Jamnagar
GUJARAT
361008
India 
Phone  9427574566  
Fax    
Email  drkspatel2007@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Kalpana S Patel 
Designation  Reader 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  Head Of the Department Department of Kaumarabhritya Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurveda University Jamnagar
Gujarat Ayurveda University Jamnagar Gujarat
Jamnagar
GUJARAT
361008
India 
Phone  9427574566  
Fax    
Email  drkspatel2007@yahoo.co.in  
 
Source of Monetary or Material Support  
Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat ayurveda University, Jamnagar. 
 
Primary Sponsor  
Name  Department of Kaumarabhritya 
Address  Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat ayurveda University, Jamnagar. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Biju KR  P.G. Ayurveda Hospital, Institute for Post Graduate Teaching and Research in Ayurveda, Jamnagar   Room No.15A Out Patient Block Department of Kaumarabhritya P.G.Ayurveda Hospital,Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurveda University, Jamnagar 361008
Jamnagar
GUJARAT 
9429807839

drbijukr@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurveda University, Jamnagar   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Obesity,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Placebo control- Wheat flour tablet  Wheat flour tablet: 5-8 tab (as per age) tds for three months, along with water (half or one glass)mixed with honey(one spoon).  
Intervention  Triphalaguduchyadi vati, low-fat diet, exercise   Triphalaguduchyadi vati: 5-8 tab (as per age) tds for three months, along with water (half or one glass) mixed with honey(one spoon).  
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  16.00 Year(s)
Gender  Both 
Details 
•Children with Body Mass Index ≥ 95th percentile for that age and sex.
•Children with signs and symptoms of Sthaulya (obesity) due to exogenous causes.
 
 
ExclusionCriteria 
Details  •Children with obesity due to endocrinal causes, genetic causes, psychiatric causes will be excluded from the study on clinical basis.
•Children suffering from severe systemic illnesses like Hypertension, Diabetes Mellitus etc will also be excluded from the study.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in Body Mass Index
 
3 months
 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in Bio Marker and Risk factors
Apolipoprotein B
LDL
Triglycerides
HDL (elevation)
Blood Pressure
Pasma Sugar level 
3 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   12/06/2010 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a randomized, placebo controlled, single blind, parallel group  trial for the efficacy of Triphalaguduchyadi vati 5-8 (as per age) tab (500 mg) tds with honey for a period of 3 months in the management of Sthaulya (Obesity) in 100 Children of 10-16 yrs old. Triphalaguduchyadi vati is a herbal preparation mentioned in Ashtanga Samgraha, one of the main classics of Ayurveda, for Obesity. Scientific names of the ingredients are Terminalia chebula (Hareetaki), Terminalia Bellerica (Vibheetaki), Emblica officinalis (Aamalaki), Tinospora cordifolia (Guduchi) and Cyperus rotundus (Musta). The primary outcome measures will be reduction in Body Mass Index after 3 months of medication.
 
Close